Solid operational aspects post-COVID, BMHS saw profit surge of nearly 200%
26 Aug 2024 11:08
As of June 2024, PT Bundamedik Tbk (BMHS) reported slight increase in revenue of 9% year-on-year (yoy) compared to H1 2021.
Profit declined, BMHS saw lowest dividend in the past three years
06 Jun 2024 08:07
PT Bundamedik Tbk (BMHS), the managing company of Rumah Sakit Bunda Hospital network, only distributes cash dividend of IDR 0.56 per share or IDR 4.82 billion for the fiscal year (FY) 2023.
Solid healthcare ecosystem, Bundamedik scored 9.25% profit growth in Q1
03 May 2024 15:21
PT Bundamedik Tbk (BMHS), the managing company of Bundar Hospital network and several diagnostic laboratories, booked net profit of IDR 10.87 billion in the first quarter of 2024.
Bundamedik’s net profit took a 91% downturn in 2023
01 Apr 2024 07:58
PT Bundamedik Tbk (BMHS), the managing company of a network of hospitals and other healthcare service providers, only scored net profit of IDR 7.46 billion in 2023.
Diagnos Laboratorium reported its first loss since debut
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.
COVID-19 crisis subsides, Diagnos Lab eyes 2023 realistically
19 Jun 2023 11:49
PT Diagnos Laboratorium Utama Tbk (DGNS), a clinical laboratory service provider under Bundamedik Group, is anticipating the decline in its revenue and profit post COVID-19 crisis.
